BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Business

  deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples

  Largest-ever Protein Measurement Study Enhances deCODE’s Efforts in Basic Research, Drug Discovery and Novel Protein-based Diagnostics

  December 13, 2018

   · 

  3 min read
• Business

  MabVax Therapeutics Engages Objective Capital as Advisor for Exploring Asset Sales

  MabVax Therapeutics Holdings, Inc. today announced that it has engaged Objective Capital Partners, LLC, to serve as a financial advisor to assist the Company in exploring the sale of clinical and preclinical assets of the Company with the goal of maximizing the value of these assets within the near term.

  December 13, 2018

   · 

  5 min read
• Drug Development

  EIP Pharma Announces Phase 2B REVERSE-SD Study of Neflamapimod Fully Enrolled

  The Phase 2b trial is being conducted in the United States, United Kingdom, Netherlands, Denmark and the Czech Republic.

  December 13, 2018

   · 

  2 min read
• Deals

  Henry Schein, Inc. Announces $400 Million Increase To Share Repurchase Plan

  Henry Schein, Inc. announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company’s common stock.

  December 13, 2018

   · 

  6 min read
• BioCapital

  AUA Announces 2019 Award Program Recipients

  The American Urological Association (AUA) is pleased to announce recipients of its 2019 AUA Awards Program. Each year, the AUA recognizes physicians, researchers, educators and other individuals for their outstanding career contributions to the field of medicine, the specialty of urology and the AUA.

  December 13, 2018

   · 

  6 min read
• Biotech Bay

  Adynxx Announces Notice Of Award For $5.7M In Federal Grant Funding

  Award intended to fund Phase 2 study of brivoligide in patients undergoing mastectomy

  December 13, 2018

   · 

  6 min read
• Business

  SiteZeus adds The Vitamin Shoppe to its Growing Retail Client Base

  SiteZeus is pleased to announce a new partnership with The Vitamin Shoppe® (NYSE: VSI), a specialty retailer that provides nutritional products across a portfolio of more than 775 company-operated stores.

  December 13, 2018

   · 

  3 min read
• BioCapital

  Incyte to Present at Upcoming January 2019 Investor Conferences

  Incyte Corporation (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of January

  December 13, 2018

   · 

  1 min read
• Business

  AtriCure to Present at the 37th Annual J.P. Morgan Healthcare Conference

  AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7, 2019.

  December 13, 2018

   · 

  1 min read
• Genetown

  Health Canada Grants Market Authorization for ORKAMBI® (lumacaftor/ivacaftor) for Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease

  ORKAMBI is the first medicine in Canada to treat the underlying cause of CF in young children with two copies of the F508del mutation

  December 13, 2018

   · 

  9 min read